Stockholm, Sweden, May 12, 2006
Full-year report and Capital Markets Day:
Elekta will issue its full-year report on fiscal year 2005/06 on June 14, at around 13.00 (1pm) CET.
This report is followed by a Capital Markets Day on June 15, at 14.00 17.00 (2-5pm) at Elektas corporate head office on Kungstensgatan 18 in central Stockholm. Call-in and webcast details will be communicated in the invitation early June. If you already now want to give notice of attendance, please send an e-mail to email@example.com.
On September 20, Elekta will issue the Q1 report for fiscal year 2006/07.
You are very welcome to these events!
For further information, please contact:
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elektas solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the worlds largest supplier of oncology software.
Elektas systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1850 employees, Elektas corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.